Affiliation: University Hospital
- Quality of care and survival of haemodialysed patients in western SwitzerlandPatrick Saudan
Division of Nephrology, University Hospital, 1211 Geneva 14, Switzerland
Nephrol Dial Transplant 23:1975-81. 2008..Many factors affect survival in haemodialysis (HD) patients. Our aim was to study whether quality of clinical care may affect survival in this population, when adjusted for demographic characteristics and co-morbidities...
- [Nephrology]P Saudan
Service de Nephrologie, HUG, 1211 Geneve 14
Rev Med Suisse 8:41-5. 2012..There is no need to initiate dialysis in asymptomatic patients, and daily haemodialysis seems better than three times weekly hemodialysis. Finally, N-acetylcysteine does not prevent contrast nephropathy...
- Renin-angiotensin system blockade and contrast-induced renal toxicityPatrick Saudan
Division of Nephrology, University Hospitals of Geneva, Geneva Switzerland
J Nephrol 21:681-5. 2008..Nevertheless, it is a common practice in many centers to stop these drugs before coronarography. Our goal was to study whether renal function was affected in patients taking ACEIs or ARBs and undergoing a coronary angiogram...
- Variability in quality of care among dialysis units in western SwitzerlandPatrick Saudan
Division of Nephrology, University Hospital of Geneva, 1211 Geneva 14, Switzerland
Nephrol Dial Transplant 20:1854-63. 2005..We analysed variations in quality indicators among dialysis facilities in western Switzerland to identify opportunities for improving care for patients with end-stage kidney disease...
- ACE inhibitors or angiotensin II receptor blockers in dialysed patients and erythropoietin resistancePatrick Saudan
Division of Nephrology, Department of Medicine, Geneva University Hospital, Switzerland
J Nephrol 19:91-6. 2006..To examine whether angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) are associated with a state of recombinant human erythropoietin (rHuEPO) resistance in hemodialyzed patients...
- [Nephrology]Patrick Saudan
Service de Nephrologie, Departement de Medecine Interne, HUG, 1211 Geneve 14
Rev Med Suisse 6:32-5. 2010....
- Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failureP Saudan
Nephrology Unit, University Hospitals of Geneva, Geneva, Switzerland
Kidney Int 70:1312-7. 2006..62) was not affected by the type of renal replacement therapy. These results suggest that increasing the dialysis dose especially for low molecular weight solutes confers a better survival in severely ill patients with ARF...
- Long-term prognosis after acute kidney injury requiring renal replacement therapyPierre Alain Triverio
Service de Nephrologie, Hopitaux Universitaires de Geneve, Geneva, Switzerland
Nephrol Dial Transplant 24:2186-9. 2009..Data on the long-term survival and renal function of patients with acute kidney injury (AKI) treated with continuous renal replacement therapy are scarce...
- Safety of low-dose spironolactone administration in chronic haemodialysis patientsPatrick Saudan
Division of Nephrology, Department of Medicine, University Hospital, Geneva Medical School, Geneva, Switzerland
Nephrol Dial Transplant 18:2359-63. 2003..We performed a study to assess whether low-dose spironolactone (3 x 25 mg/week) could be administered without inducing hyperkalaemia in haemodialysis patients...
- [Bisphosphonate-induced collapsing focal segmental glomerulosclerosis; two clinical cases and literature review]Valerie Jotterand
Service de médecine interne générale, Hopitaux Universitaires de Geneve, Rue Micheli du Crest, 24, 1211 Geneve 14, Switzerland
Nephrol Ther 5:134-8. 2009..For patients with chronic kidney disease, introduction of bisphosphonates should be reconsidered given the risk of rapid progression to end stage renal disease and the lack of evidence for reduction of fracture risk in this population...
- [Acute renal failure in 2008]Belen Ponte
Service de Nephrologie, Hôpital universitaire Ramon y Cajal, 28000 Madrid, Espagne
Rev Med Suisse 4:568, 570-2, 574-5. 2008..Therefore, earlier detection and prevention of frequent causes of acute renal failure in patients at risk are of paramount importance...
- [Drugs dosing in intensive care unit during continuous renal replacement therapy]Vincent Bourquin
Service de Nephrologie, Departement de Medecine Interne, Hopitaux Universitaires de Geneve HUG, 1211 Geneve, Suisse
Nephrol Ther 5:533-41. 2009..Monitoring the plasma level of drug - when available - can establish a relation between the blood concentration and its effect; thus, facilitating drug dosing...
- Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled studySophie de Seigneux
Service of Nephrology, Department of Medical Specialties, Geneva University Hospitals, Rue Gabrielle Perret Gentil 4, 1211, Geneva, Switzerland
BMC Nephrol 13:132. 2012....
- I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicityPierre Alexandre Poletti
Department of Radiology, University Hospital of Geneva, 24, Rue Micheli du Crest, 1211 Geneve 14, Switzerland
AJR Am J Roentgenol 189:687-92. 2007..v. administration of N-acetylcysteine (NAC) on serum levels of creatinine and cystatin C, two markers of renal function, in patients with renal insufficiency who undergo emergency contrast-enhanced CT...
- Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patientsPierre Alain Triverio
Division of Nephrology, Geneva University Hospital, 1211 Geneva 14, Switzerland
Nephrol Dial Transplant 24:1952-6. 2009..End stage renal disease increases the risk of reactivating latent tuberculosis (LTBI). Interferon-gamma release assays (IGRA) are an alternative to the tuberculin skin test (TST) for detecting LTBI...
- [Paraproteinemia and renal diseases]Anne Pascale Grandjean
Service de médecine interne générale, HUG, 1211 Geneve 14
Rev Med Suisse 6:460-6. 2010..Autologous hematopoietic cell transplantation remains the standard of care treatment for eligible patients...
- [Hypertension in pregnancy]Laurence Clivaz Mariotti
Service de médecine communautaire, Departement de Medecine Interne, HUG, 1211 Geneve 14
Rev Med Suisse 3:2012, 2015-6, 2018 passim. 2007..Angiotensin converting enzymes inhibitors and angiotensin II receptor blockers are contraindicated, even during the first trimester of pregnancy. The prescription of diuretics during pregnancy should be avoided...
- [Is hyperuricemia involved in the pathogenesis of hypertension and renal insufficiency?]Soraya Hadjeres
Service de médecine interne générale, HUG, 1211 Geneve 14
Rev Med Suisse 5:451-2, 454-6. 2009....
- Satisfaction of patients on chronic haemodialysis and peritoneal dialysisJean Blaise Wasserfallen
University Hospital Lausanne Chuv, Lausanne, Switzerland
Swiss Med Wkly 136:210-7. 2006..In contrast to quality of life, patient satisfaction on chronic haemodialysis (HD) and peritoneal dialysis (PD) has only rarely been studied...
- Quality of life on chronic dialysis: comparison between haemodialysis and peritoneal dialysisJean Blaise Wasserfallen
University Hospital Lausanne, Switzerland
Nephrol Dial Transplant 19:1594-9. 2004..Quality of life (QOL) assessment in patients on chronic haemodialysis (HD) or peritoneal dialysis (PD) has only rarely been carried out with the generic Euroqol-5D questionnaire...